Previous 10 | Next 10 |
Merger activity increased last week with three new deals announced and one deal closing. The biggest highlight for last week was the acquisition of Maxim Integrated Products (MXIM) by Analog Devices (ADI) in an all-stock deal for $21 billion, which is the largest deal so far this year. The...
Merger activity remained steady last week with one new deal announced, six deals closing and one deal called off. The month of June ended with six active deals being completed and another deal terminated, resulting in a total of five deals terminated in a single month. June was also the most...
Merger activity decreased last week with one new deal announced, two deals closing, and one deal called off. After terminating deals with AcelRx Pharmaceuticals (ACRX) and Melinta Therapeutics (MLNT), Tetraphase Pharmaceuticals (TTPH) agreed to be acquired by La Jolla Pharmaceutical Company ...
La Jolla Pharmaceutical (NASDAQ: LJPC ) and Tetraphase Pharmaceuticals (NASDAQ: TTPH ) have entered into a definitive merger agreement, under which La Jolla would acquire Tetraphase, through a tender offer, for $43M in upfront cash plus potential future cash payments of up to $16M pursuant...
La Jolla agreement provides for $43.0 million in upfront cash plus potential future cash payments of up to $16.0 million pursuant to contingent value rights Combined company will offer two innovative therapies to treat patients suffering from life-threatening diseases SAN DIEGO, Ca...
The bidding competition for Tetraphase Pharmaceuticals (NASDAQ: TTPH ) is not over yet. La Jolla Pharmaceutical (NASDAQ: LJPC ) has submitted an unsolicited bid of $43.0M in cash plus an additional $16.0 payable under contingent value rights (CVRs). More news on: Tetraphase Pharmaceutica...
Protagonist Therapeutics (PTGX) is a relatively unknown biotech company focused on the development of novel peptide drugs. The company has recently shown exciting data for their hepcidin mimetic drug PTG-300 in Polycythemia Vera ("PV") which resulted in a doubling of their share price. In this...
The Nasdaq hit an all-time high intraday on Friday and the recovery from the March lows almost appears to be complete. The S&P 500 is lagging behind a bit and the Russell 2000 index of small-cap stocks is still off more than 13% from its February high. The stock market rally has come as a ...
Gainers: Hertz Global (NYSE: HTZ ) +104% . More news on: Hertz Global Holdings, Inc., Euroseas Ltd., Mersana Therapeutics, Inc., Stocks on the move, , Read more ...
Signaling its determination to close the deal amid rival offers, AcelRx Pharmaceuticals ( ACRX -4.0% ) has increased its bid for Tetraphase Pharmaceuticals ( TTPH -8.3% ) to $30M in cash and stock plus an additional $14.5M in cash payable under a contingent value right (CVR). More news...
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
La Jolla Pharmaceutical Company Website:
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...